Furthermore, the superiority of OELyso-Gal was demonstrated in real-time visualization of ovarian cancer in tumour-bearing mice, which is the first in vivo implementation with a lysosome-targeting probe activated by β-gal. This evidence concerns the gene GAL and ovarian cancer.